Clinical Alternatives for Reducing Harm Using E-cigarettes
Enrolling by invitation · Not applicable
Conditions studied: Smoking, E-Cig Use, Oncology
In brief
For patients in cancer care, quitting smoking is critical, but a significant portion of patients in cancer care refuse all components of tobacco treatment, even when offered free of charge. The proposed clinical trial will assess one harm reduction intervention, switching completely from cigarettes to e-cigarettes, among oncology outpatients who smoke and refuse traditional tobacco treatment. This study is a type 1 hybrid effectiveness-implementation trial among oncology outpatients at an NCI-designated cancer center who smoke and refuse all components of tobacco treatment (N=208).
Key facts
- Study ID
- NCT07039292
- Run by
- Medical University of South Carolina
- People needed
- 208
- Starts
- 2025-08-25
- Expected to finish
- 2029-11-30
- Last updated by the study team
- 2026-05-08
Who can join
Age: 21 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- age 21+,
- identified as smoking in their medical record and self-report of current smoking within the past 30 days
- refused traditional treatment options through the opt-out HCC Tobacco Treatment Program
- English speaking;
You may not qualify if…
- currently taking part in any TTP or using cessation medication (i.e., taking NRT or other cessation medications, enrolled in the Quitline, or in another study),
- use of e-cigarettes in the past 30 days,
- currently imprisoned,
- pregnant women.
Where it is running
- Medical University of South Carolina — Charleston, South Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.